Go back to:   
 
 

The Council on Menopause Management
2009 Menopause Management Highlights

Release Date: October 15, 2009
Expiration Date: October 14, 2010

To Download Newsletter:
Please scroll through this page to read all the disclosures and important information. Then click the Download PDF button at the bottom of the page to continue.
 
 

The 2009 Council on Menopause Management

The 2009 Menopause Council convened in Chicago to objectively discuss the most current research and thinking regarding optimal clinical management of several conditions and health issues in menopausal women including: Cardiovascular Health, Bone Health, Breast Cancer, Quality of Life and Sexual Dysfunction, Thromboembolism, and Cognitive Function and Dementia.

The Newsletter highlights the latest information about menopause management issues, including quality of life, hormone therapy and its risks versus benefits, nonhormonal prescription therapies for menopausal symptoms, and the health risks associated with menopause itself. Also addressed are results of research on the use of botanical supplements and alternative therapies for relief of symptoms.
   
  Follow us on Twitter  

 
  Signup for our iphone app
 
   

Disclosures and Important Information


Sponsored by the Duke University School of Medicine

In collaboration with

Supported by an educational grant from Wyeth

Release Date: October 15, 2009

Expiration Date: October 14, 2010

Estimated time to complete this activity: 1.0 hour

Accreditation Statement

The Duke University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement

The Duke University School of Medicine designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

"The Council on Menopause Management" has been reviewed and is acceptable for up to 4.0 Prescribed credits by the American Academy of Family Physicians. AAFP accreditation begins September 15, 2009. Term of approval is for one year from this date. (This newsletter is approved for 1.0 Prescribed credits. Credit may be claimed for 1 year from the date of this activity).

Course Co-chairs and Principal Faculty

Charles B. Hammond, MD (Co-chair)
E. C. Hamblen Professor
Chair Emeritus, Department of Obstetrics and Gynecology
Reproductive Endocrinology and Fertility
Duke University Medical Center
Durham, NC

Michelle P. Warren, MD (Co-chair)
Medical Director, Center for Menopause, Hormonal
Disorders and Women's Health
Department of Obstetrics and Gynecology
Columbia University Medical Center
New York, NY

Target Audience

This activity is intended for gynecologists, family practitioners, internists, and other practitioners who care for menopausal women.

Prerequisites

There are no prerequisites.

Statement of Need

Menopause-related vasomotor symptoms can diminish menopausal women's quality of life. With so many different types of interventions available for the treatment of vasomotor symptoms, women should be active participants in the treatment decision-making process.

This educational activity has been designed to facilitate application of the latest research and guidelines to help clinicians improve counseling, management, treatment, and care of menopausal women with the ultimate goal of increasing their longevity and quality of life.

Objectives

After completing this activity, you should be able to:

  • Describe the impact of menopause on life functions and quality of life
  • Discuss the effects of hormone therapy (HT) on menopause symptoms
  • Identify the effects of SSRIs, SSNRIs, and gabapentin on hot flushes, mood, and depression
  • Discuss the use of alternative agents for the management of menopause therapy

Method of Participation

This Internet-based activity takes approximately 1 hour to complete. You should review the objectives and newsletter, answer the multiple-choice post-test and complete an evaluation form online. Once completed, you will be able to save your certificate to your own computer and print it on your own printer.

Resolution of Conflicts of Interest

In accordance with the ACCME Standards for Commercial Support of CME, the Duke University School of Medicine implemented mechanisms, prior to the planning and implementation of this CME activity, to identify and resolve conflicts of interest for all individuals in a position to control content of this CME activity.

Staff and Content Validation Reviewer Disclosure

The staff involved with this activity and any content validation reviewers of this activity have reported no relevant financial relationships with commercial interests.

Planning Committee/Faculty Disclosure

The following planning committee members have indicated they have no relationship(s) with industry to disclose relative to the content of this CME activity: Brian McDonough, MD; Carolyn Darrow, MPH; Lillie Chen; and Daryl Ehrentreu, RPh, MBA.

The following speakers and/or planning committee members have indicated that they have relationship(s) with industry to disclose:

David Archer, MD Consultant: Bayer, Schering Plough Organon, Agile Therapeutics, Radius Pharmaceuticals Inc, Xanodyne
PI: Wyeth, Bayer, Schering Plough Organon, Zanodyne
Speaker: Wyeth, Schering Plough Organon
Charles B. Hammond, MD Board Member and Scholar Award: Bayer Pharmaceuticals
Michelle P. Warren, MD Consultant: Barr Laboratories (Duramed), Bradley Pharmaceuticals, Ferring, QuatRx, Warner Chilcott, National Cattlemans Beef Association
Speaker: Novartis, Novo Nordisk, Upsher Smith, Warner Chilcott, Wyeth Pharmaceuticals Inc.
PI: Novartis, Solvay, Wyeth Pharmaceuticals, Inc., Ferring
Solicited Manuscript: Up to Date
Advisory Board Member: Yoplait
Wyeth-Ayerst Professor of Woman's Health: Wyeth Pharmaceuticals, Inc.

Unapproved Use Disclosure

Duke School of Medicine requires CME faculty (speakers) to disclose to attendees when products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not FDA approved); and any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty may discuss information about pharmaceutical agents that is outside of U.S. Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information. No faculty member has indicated that their presentation will include information on off-label products.

Disclaimer

The information provided in this CME activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition.

The opinions and recommendations expressed by faculty and other experts whose input is included in this activity are their own.

The MedCases Web site does not define a standard of care, nor is it intended to dictate an exclusive course of management. Cases are provided for informational and educational purposes only and are not intended as medical advice. This information should not substitute for a visit or consultation with a health care provider.

Privacy Statement

MedCases is committed to maintaining site visitor's rights to privacy and confidentiality of personal information. Personal information about site visitors and specific visitor's access and navigation, and information volunteered by site visitors, such as survey information and site registration information, may be used by MedCases to improve the site but will not be shared with or sold to other organizations for commercial purposes without the site visitor's express permission.
Please click here to read MedCases' detailed privacy policy and other terms of using this web site.

Copyright Information

© 2009 MedCases, LLC and Duke University School of Medicine

For Further Information:

MedCases
4365 US Highway 1, Suite 207
Princeton, NJ 08540
Phone (609) 454-0680
Fax (609) 951-0112
cme@medcases.com

For Questions/Information Regarding CME Credits:

Duke University School of Medicine Office of CME
3100 Tower Boulevard, Suite 1300
Durham, NC 27707
Phone (919) 401-1200
Fax (919) 401-1213
cme@mc.duke.edu
http://cme.mc.duke.edu

Hardware/Software Requirements and Technical Assistance

This Web-based CME activity is best experienced using a current generation browser, such as Internet Explorer 5.5 or higher. This Web site requires that JavaScript and session cookies be enabled. In addition, you will require the Adobe Acrobat Reader to view the downloaded PDF.

Detailed Requirements:

  • 128 MB RAM
  • Windows 98 or newer
  • Adobe Flash Player 8 minimum needed
  • Audio playback with speakers for programs that have video content
  • Internet Explorer 5.5 or higher or Mozilla Firefox 1.0 or higher or Apple Safari
  • 1024 x 768 resolution
  • Broadband connection highly recommended

More information about the software described above is available at the links below:

If you need assistance, please use the help link above to contact technical support.


Confirmation

By clicking the Download PDF button below, you are confirming that you have read all the disclosures and important information on this page. Once you have read the newsletter, you may proceed to the Post-Test/Evaluation to answer the multiple-choice post-test and complete an evaluation form to obtain your certificate.

 
   
 
   

 
 
Please enter your e-mail address: